Suppressive effect of rice extract on Helicobacter pylori infection in a Mongolian gerbil model

Journal of Gastroenterology

Volumn 40, Issue 5, 2005, Pages 459-466

  Murakami, Maki ^a,c   Ota, Hiroyoshi ^a   Sugiyama, Atsushi ^a   Ishizone, Satoshi ^a   Maruta, Fukuto ^a   Akita, Noriyuki ^a   Okimura, Yukie ^b   Kumagai, Toshiko ^b   Jo, Megumi ^d   Tokuyama, Takashi ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c Jishyukai Ueda Kidney Clinic   (Japan)

^d Development Division   (Japan)

Author keywords

Gastric mucosal cell proliferation; Gastritis; Helicobacter pylori; Mongolian gerbils; Rice extract

Indexed keywords

BROXURIDINE; EOSIN; HEMATOXYLIN; PLANT EXTRACT; RICE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM DETECTION; CELL INFILTRATION; CHRONIC GASTRITIS; CONTROLLED STUDY; ERADICATION THERAPY; GASTRITIS; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RICE; STOMACH MUCOSA; STOMACH PROTECTION;

ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GASTRITIS; GERBILLINAE; HELICOBACTER INFECTIONS; IMMUNOHISTOCHEMISTRY; MALE; ORYZA SATIVA; PHYTOTHERAPY; PLANT PREPARATIONS; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 20444506086     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1570-7     Document Type: Article

References (40)

1. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risk Hum 1994;611:177-240.
2. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
3. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, et al. Helicobacter pylori infection enhances MNU (N-methyl-N-nitrosourea) - induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998;58:2067-9.
4. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
5. Hirayama F, Takagi S, Yokoyama Y, Iwao E, Ikeda Y. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol 1996;31(Suppl IX):24-8.
6. Matsumoto S, Washizuka Y, Matsumoto H, Tawara F, Ikeda F, Yokota Y, et al. Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. J Med Microbiol 1997;46:391-7.
7. Takahashi S, Keto Y, Fujita H, Muramatsu H, Nishio T, Okabe S. Pathological changes in the formation of Helicobacter pylori - induced gastric lesions in Mongolian gerbils. Dig Dis Sci 1998; 43:754-65.
8. Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, et al. Helicobacter pylori - induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 1999;154:951-60.
9. Tatematsu M, Yamamoto M, Shimizu N, Yoshikawa A, Fukami H, Kaminishi M, et al. Induction of glandular stomach cancers in Helicobacter pylori - sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N′-nitrosoguanidine in drinking water. Jpn J Cancer Res 1998;89:97-104.
10. Murakami M, Sugiyama A, Ota H, Maruta F, Ikeno T, Hayama M, et al. Duodenogastric reflux and Helicobacter pylori infection synergistically increase gastric mucosal cell proliferative activity in Mongolian gerbils. Scand J Gastroenterol 2003;38:370-9.
11. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 (Suppl):116-28.
12. Furihata C, Ishida S, Ohta H, Tokuyama T, Katsuyama T, Ogita Z. Cytotoxicity of NaCl, a stomach tumor promoter, and prevention by rice extract in stomach mucosa of F344 rats. Cancer Detect Prev 1996;20:193-8.
13. Kumagai T, Yan J, Graham DY, Tozuka M, Okimura Y, Ikeno T, et al. Serum immunoglobulin G immune response to Helicobacter pylori antigens in Mongolian gerbils. J Clin Microbiol 2001;39: 1283-8.
14. Maruta F, Ota H, Genta RM, Sugiyama A, Tatematsu M, Katsuyama T, et al. Role of N-methyl-N-nitrosourea in the induction of intestinal metaplasia and gastric adenocarcinoma in Mongolian gerbils with Helicobacter pylori. Scand J Gastroenterol 2001;36:283-90.
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 1996;20:86-92.
16. Goodwin CS, Blake P, Blincow E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986; 17:309-14.
17. Lambert T, Megraud F, Gerbaud G, Courvalin P. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother 1986;30:510-1.
18. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
19. Mertens JC, Dekker W, Lightvoet EE, Blok P. Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia. Antimicrob Agents Chemother 1989;33:256-7.
20. Axon ATR, Moayyedi P. Eradication of Helicobacter pylori: Omeprazole in combination with antibiotics. Scand J Gastroenterol 1996;31 (Suppl 215):82-9.
21. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, et al. One week triple therapy for Helicobacter pylori: A multicentre comparative study. Gut 1997;41:735-9.
22. Borody TJ, Shortis NP, Reyes E. Eradication therapies for Helicobacter pylori. J Gastroenterol 1998;33 (Suppl 10): 53-6.
23. Ling TK, Cheng AF, Sung JJ, Yiu PY, Chung SS. An increase in Helicobacter pylori strains resistance to metronidazole: A 5-year study. Helicobacter 1996;1:57-61.
24. Matsumoto S, Washizuka Y, Matsumoto Y, Tawara S, Ikeda F, Yokota Y, et al. Appearance of metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains. Antimicrob Agents Chemother 1997;41:2602-5.
25. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996;11:290-2.
26. Mabe K, Yamada M, Oguni I, Takahashi Y. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 1999;43:1788-91.
27. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 2002;99:7610-5.
28. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001;47:709-10.
29. Murakami M, Sugiyama A, Ota H, Ishizone S, Maruta F, Sato T, et al. The effect of rice extract on Helicobacter pylori-infected gastritis in Mongolian gerbils (in Japanese with English abstract). Ulcer Res 2003;30:93-6.
30. Sun YQ, Soderholm JD, Petersson F, Borch K. Longstanding gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2004; 9:217-27.
31. Rodriguez P, Heyman M, Candalh C, Blaton MA, Bouchaud C. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 1995;7:441-8.
32. Terpend K, Boisgerault F, Blaton MA, Desjeux JF, Heyman M. Protein transport and processing by human HT29-19A intestinal cells: Effect of interferon gamma. Gut 1998;42:538-45.
33. Fukuzawa K, Noguchi Y, Matsumoto A. Alterations in DNA proliferation in gastric stump mucosa with special reference to topography. Surgery 1996;119:191-7.
34. Guadagni S, Pistoia MA, Amicucci G, Leocata P, Ventura L, Ventura T, et al. N-Nitroso compounds and Helicobacter pylori in the gastric remnant. Tumori 1999;85:108-12.
35. Lipkin M, Blattner WE, Fraumeni JF Jr, Lynch HT, Deschner E, Winawer S. Tritiated thymidine labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983; 43:1899-904.
36. Deschner EE. Cell proliferation and colonic neoplasia. Scand J Gastroenterol 1988;23 (Suppl 151):94-7.
37. Keress S, Allen A, Garner A. A simple method for measuring thickness of the mucous gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, Nacetylcysteine and other agents. Clin Sci 1982;63:187-95.
38. Terano A, Hiraishi H, Ota S, Sugimoto T. Arachidonic acid stimulation of mucus production by rat gastric cultured cells. Dig Dis Sci 1987;32:878-82.
39. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rat. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979;77:433-43.
40. Sugiyama A, Ikeno T, Ishida K, Maruta F, Murakami M, Sato T, et al. Paradoxical role of Helicobacter pylori infection. Protective effect against ethanol-induced gastric mucosal injury in Mongolian gerbils. Dig Dis Sci 2001;46:2433-9.